U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 71

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr22:21348898
GRCh38:
Chr22:20994609
LZTR1S556NNoonan syndrome 10, not providedUncertain significance
(Apr 10, 2022)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr22:21340139-21340140
GRCh38:
Chr22:20985850-20985851
LZTR1Noonan syndrome 10Likely pathogenic
(Oct 19, 2020)
criteria provided, single submitter
3.
GRCh37:
Chr22:21342314
GRCh38:
Chr22:20988025
LZTR1D139GNoonan syndrome 10Likely pathogenic
(Sep 2, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr22:21337324
GRCh38:
Chr22:20983035
LZTR1K70MNoonan syndrome 10Uncertain significancecriteria provided, single submitter
5.
GRCh37:
Chr22:21351090
GRCh38:
Chr22:20996801
LZTR1Q775HCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10
Uncertain significance
(Jul 6, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr22:21341842
GRCh38:
Chr22:20987553
LZTR1V124IHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10,
not provided
Uncertain significance
(Jun 14, 2023)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr22:21342341
GRCh38:
Chr22:20988052
LZTR1N148SNoonan syndrome 10, Noonan syndrome 2, not provided
Uncertain significance
(Apr 26, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr22:21340161
GRCh38:
Chr22:20985872
LZTR1D99YNoonan syndrome 10Uncertain significance
(Oct 12, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr22:21351584
GRCh38:
Chr22:20997295
LZTR1L824VNoonan syndrome 10, not providedUncertain significance
(Jun 22, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr22:21336823
GRCh38:
Chr22:20982534
LZTR1R55WHereditary cancer-predisposing syndrome, Cardiovascular phenotypeUncertain significance
(Sep 9, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr22:21348906-21348907
GRCh38:
Chr22:20994617-20994618
LZTR1Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10
Uncertain significance
(Jan 10, 2023)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr22:21346018-21346021
GRCh38:
Chr22:20991729-20991732
LZTR1F299fsNoonan syndrome 2, Noonan syndrome 10Uncertain significance
(Jun 11, 2021)
criteria provided, single submitter
13.
GRCh37:
Chr22:21346650
GRCh38:
Chr22:20992361
LZTR1A381PNoonan syndrome 10Uncertain significance
(May 4, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr22:21346587
GRCh38:
Chr22:20992298
LZTR1K360*Schwannomatosis 2, Noonan syndrome 2, Noonan syndrome 10
Likely pathogenic
(Sep 9, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr22:21348920
GRCh38:
Chr22:20994631
LZTR1Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10,
not provided
Conflicting interpretations of pathogenicity
(Jul 25, 2023)
criteria provided, conflicting interpretations
16.
GRCh37:
Chr22:21347168
GRCh38:
Chr22:20992879
LZTR1R412HHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Schwannomatosis 2,
Noonan syndrome 2, Noonan syndrome 10, not provided
Conflicting interpretations of pathogenicity
(May 21, 2022)
criteria provided, conflicting interpretations
17.
GRCh37:
Chr22:21350034
GRCh38:
Chr22:20995745
LZTR1Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Schwannomatosis 2,
Noonan syndrome 2, Noonan syndrome 10, not provided
Likely pathogenic
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr22:21336682
GRCh38:
Chr22:20982393
LZTR1G8RNoonan syndrome 10, not provided, Hereditary cancer-predisposing syndrome,
Cardiovascular phenotype
Uncertain significance
(Mar 31, 2023)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr22:21342363
GRCh38:
Chr22:20988074
LZTR1Y155*not provided, Noonan syndrome 2, Noonan syndrome 10,
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype
Pathogenic/Likely pathogenic
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr22:21341845
GRCh38:
Chr22:20987556
LZTR1V125IHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10,
not provided
Uncertain significance
(Aug 1, 2023)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr22:21349318
GRCh38:
Chr22:20995029
LZTR1Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, not provided,
Noonan syndrome 2, Schwannomatosis 2, Noonan syndrome 10
Uncertain significance
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr22:21348208
GRCh38:
Chr22:20993919
LZTR1Noonan syndrome 10, not specified, Hereditary cancer-predisposing syndrome,
Cardiovascular phenotype, not provided
Uncertain significance
(Nov 16, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr22:21340187
GRCh38:
Chr22:20985898
LZTR1Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10
Likely pathogenic
(Nov 12, 2021)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr22:21343095
GRCh38:
Chr22:20988806
LZTR1S176LCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10
Uncertain significance
(Jul 15, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr22:21351615-21351616
GRCh38:
Chr22:20997326-20997327
LZTR1A834fsNoonan syndrome 10Pathogenic
(Oct 2, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr22:21342406
GRCh38:
Chr22:20988117
LZTR1R170Wnot provided, Noonan syndrome 10, Hereditary cancer-predisposing syndrome,
Cardiovascular phenotype
Uncertain significance
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr22:21346071
GRCh38:
Chr22:20991782
LZTR1V316Mnot provided, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome,
Noonan syndrome 10, not specified
Uncertain significance
(Mar 2, 2023)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr22:21350271
GRCh38:
Chr22:20995982
LZTR1R697WCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10,
not provided
Uncertain significance
(May 23, 2023)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr22:21351623
GRCh38:
Chr22:20997334
LZTR1G837SNoonan syndrome 10Uncertain significance
(Mar 23, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr22:21350355
GRCh38:
Chr22:20996066
LZTR1R725CNoonan syndrome 10, Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype,
Hereditary cancer-predisposing syndrome
Uncertain significance
(Feb 1, 2021)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr22:21347187
GRCh38:
Chr22:20992898
LZTR1R418SCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10,
not provided
Uncertain significance
(Aug 25, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr22:21336718
GRCh38:
Chr22:20982429
LZTR1A20THereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10,
not provided
Uncertain significance
(Aug 14, 2021)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr22:21341794
GRCh38:
Chr22:20987505
LZTR1A108TNoonan syndrome 10Uncertain significance
(Apr 3, 2019)
criteria provided, single submitter
34.
GRCh37:
Chr22:21350240
GRCh38:
Chr22:20995951
LZTR1Noonan syndrome 10Uncertain significance
(Feb 3, 2020)
criteria provided, single submitter
35.
GRCh37:
Chr22:21346113
GRCh38:
Chr22:20991824
LZTR1S330GCardiovascular phenotype, Hereditary cancer-predisposing syndrome, not provided,
Noonan syndrome 10
Uncertain significance
(Aug 18, 2023)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr22:21350070
GRCh38:
Chr22:20995781
LZTR1E660KCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10,
not provided
Uncertain significance
(Jan 20, 2023)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr22:21351025
GRCh38:
Chr22:20996736
LZTR1N754HHereditary cancer-predisposing syndrome, Cardiovascular phenotype, not provided,
Noonan syndrome 10
Uncertain significance
(May 31, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr22:21342302
GRCh38:
Chr22:20988013
LZTR1G135VCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10,
not provided
Uncertain significance
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr22:21351551
GRCh38:
Chr22:20997262
LZTR1S813Rnot provided, Noonan syndrome 10Uncertain significance
(Sep 24, 2021)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr22:21347187
GRCh38:
Chr22:20992898
LZTR1R418SNoonan syndrome 10Uncertain significance
(Jun 5, 2020)
criteria provided, single submitter
41.
GRCh37:
Chr22:21349017
GRCh38:
Chr22:20994728
LZTR1Noonan syndrome 10Pathogeniccriteria provided, single submitter
42.
GRCh37:
Chr22:21344745
GRCh38:
Chr22:20990456
LZTR1F241SNoonan syndrome 2, Noonan syndrome 10Likely pathogenic
(Jul 7, 2020)
no assertion criteria provided
43.
GRCh37:
Chr22:21348931
GRCh38:
Chr22:20994642
LZTR1R567HCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Schwannomatosis 2,
Noonan syndrome 10, not provided, not specified
Conflicting interpretations of pathogenicity
(Jan 24, 2023)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr22:21351028
GRCh38:
Chr22:20996739
LZTR1R755WNoonan syndrome 10, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype,
not specified, not provided
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr22:21348851
GRCh38:
Chr22:20994562
LZTR1Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, not specified,
Noonan syndrome 10, Noonan syndrome 2, Schwannomatosis 2,
not provided
Benign/Likely benign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr22:21344733
GRCh38:
Chr22:20990444
LZTR1R237QCardiovascular phenotype, Hereditary cancer-predisposing syndrome, not provided,
Noonan syndrome 10
Uncertain significance
(Dec 29, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr22:21349285
GRCh38:
Chr22:20994996
LZTR1R638CCardiovascular phenotype, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr22:21348528
GRCh38:
Chr22:20994239
LZTR1Y529HNoonan syndrome 10Uncertain significance
(Aug 25, 2019)
no assertion criteria provided
49.
GRCh37:
Chr22:21351010
GRCh38:
Chr22:20996721
LZTR1Y749HNoonan syndrome 2, Noonan syndrome 10Uncertain significanceno assertion criteria provided
50.
GRCh37:
Chr22:21341832
GRCh38:
Chr22:20987543
LZTR1H120QNoonan syndrome 10Uncertain significancecriteria provided, single submitter
51.
GRCh37:
Chr22:21343948
GRCh38:
Chr22:20989659
LZTR1R210*Noonan syndrome 10, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome,
Schwannomatosis 2, not provided
Pathogenic
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr22:21347993
GRCh38:
Chr22:20993704
LZTR1R435WNoonan syndrome 10, not provided, Cardiovascular phenotype,
Hereditary cancer-predisposing syndrome
Uncertain significance
(Jun 30, 2023)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr22:21345973
GRCh38:
Chr22:20991684
LZTR1R283QRASopathy, Noonan syndrome and Noonan-related syndrome, Noonan syndrome 10,
not provided
Conflicting interpretations of pathogenicity
(Feb 23, 2023)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr22:21345967
GRCh38:
Chr22:20991678
LZTR1P281Lnot specified, not provided, Inborn genetic diseases,
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10
Conflicting interpretations of pathogenicity
(Aug 14, 2023)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr22:21348970
GRCh38:
Chr22:20994681
LZTR1L580PNoonan syndrome 10Uncertain significanceno assertion criteria provided
56.
GRCh37:
Chr22:21336623
GRCh38:
Chr22:20982334
LZTR1Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 2,
Schwannomatosis 2, Noonan syndrome 10, Noonan syndrome 2,
not provided, Noonan syndrome 2, Noonan syndrome 10
Conflicting interpretations of pathogenicity
(Jun 18, 2022)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr22:21340138
GRCh38:
Chr22:20985849
LZTR1M91TNoonan syndrome 10, not providedConflicting interpretations of pathogenicity
(Oct 3, 2019)
criteria provided, conflicting interpretations
58.
GRCh37:
Chr22:21336686
GRCh38:
Chr22:20982397
LZTR1G9AInborn genetic diseases, Noonan syndrome 10, Hereditary cancer-predisposing syndrome,
Cardiovascular phenotype, not specified, not provided
Conflicting interpretations of pathogenicity
(Feb 20, 2023)
criteria provided, conflicting interpretations
59.
GRCh37:
Chr22:21346527
GRCh38:
Chr22:20992238
LZTR1R340*not provided, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome,
Noonan syndrome 10, not specified, Schwannomatosis 2
Conflicting interpretations of pathogenicity
(Sep 25, 2023)
criteria provided, conflicting interpretations
60.
GRCh37:
Chr22:21336719
GRCh38:
Chr22:20982430
LZTR1A20VHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10,
not provided
Uncertain significance
(Jan 16, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr22:21350074
GRCh38:
Chr22:20995785
LZTR1G661Enot provided, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype,
Noonan syndrome 10
Uncertain significance
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr22:21349277
GRCh38:
Chr22:20994988
LZTR1P635Lnot provided, not specified, Hereditary cancer-predisposing syndrome,
Cardiovascular phenotype
Conflicting interpretations of pathogenicity
(Nov 4, 2022)
criteria provided, conflicting interpretations
63.
GRCh37:
Chr22:21340137
GRCh38:
Chr22:20985848
LZTR1M91Vnot provided, Noonan syndrome 10, RASopathy
Uncertain significance
(Nov 1, 2021)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr22:21348981
GRCh38:
Chr22:20994692
LZTR1E584KCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10,
not provided, not specified
Uncertain significance
(Aug 1, 2023)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr22:21347167
GRCh38:
Chr22:20992878
LZTR1R412Cnot specified, Non-immune hydrops fetalis, not provided,
Noonan syndrome and Noonan-related syndrome, RASopathy, Schwannomatosis 2,
Noonan syndrome 10
Conflicting interpretations of pathogenicity
(Jul 1, 2023)
criteria provided, conflicting interpretations
66.
GRCh37:
Chr22:21346593
GRCh38:
Chr22:20992304
LZTR1R362*Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 2,
not provided, Schwannomatosis, Schwannomatosis 2,
Noonan syndrome 10, Noonan syndrome and Noonan-related syndrome, Schwannomatosis 2,
See cases
Pathogenic/Likely pathogenic
(Jul 7, 2023)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr22:21344763
GRCh38:
Chr22:20990474
LZTR1S247NNoonan syndrome 10Pathogenic
(Jun 1, 2015)
no assertion criteria provided
68.
GRCh37:
Chr22:21345975
GRCh38:
Chr22:20991686
LZTR1R284CHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10,
Noonan syndrome 10, Schwannomatosis 2, not provided
Pathogenic
(Jun 1, 2023)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr22:21344765
GRCh38:
Chr22:20990476
LZTR1G248RCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Inborn genetic diseases,
Schwannomatosis 2, Noonan syndrome 10, Fetal cystic hygroma,
Noonan syndrome 10, not provided, RASopathy
Pathogenic/Likely pathogenic
(Dec 27, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr22:21336681
GRCh38:
Chr22:20982392
LZTR1Q10fsHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10,
not provided
Pathogenic
(Mar 2, 2023)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr22:21340117
GRCh38:
Chr22:20985828
LZTR1Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 2,
Noonan syndrome 10, Schwannomatosis 2, Schwannomatosis 2,
Developmental disorder, not provided, RASopathy
Conflicting interpretations of pathogenicity
(Oct 18, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination